The store will not work correctly when cookies are disabled.
N-(2-carbamoylphenyl)-5-nitrobenzo[b]thiophene-2-carboxamide
ID: ALA4467914
Cas Number: 690693-02-8
PubChem CID: 2928882
Max Phase: Preclinical
Molecular Formula: C16H11N3O4S
Molecular Weight: 341.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccccc1NC(=O)c1cc2cc([N+](=O)[O-])ccc2s1
Standard InChI: InChI=1S/C16H11N3O4S/c17-15(20)11-3-1-2-4-12(11)18-16(21)14-8-9-7-10(19(22)23)5-6-13(9)24-14/h1-8H,(H2,17,20)(H,18,21)
Standard InChI Key: BTTXJIMSRRTAQM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
8.9382 -21.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9370 -22.1738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6451 -22.5827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6433 -20.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3519 -21.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3567 -22.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1367 -22.4177 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.6141 -21.7526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1290 -21.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4313 -21.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8440 -22.4531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8357 -21.0377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6528 -21.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0635 -21.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8800 -21.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2852 -21.0249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8680 -20.3173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0530 -20.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2297 -20.9461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5220 -21.3548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2295 -20.1289 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6378 -19.6214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0398 -18.9099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8206 -19.6290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 2 0
19 21 1 0
1 19 1 0
18 22 1 0
22 23 1 0
22 24 2 0
M CHG 2 19 1 21 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.35 | Molecular Weight (Monoisotopic): 341.0470 | AlogP: 3.16 | #Rotatable Bonds: 4 |
Polar Surface Area: 115.33 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.64 | CX Basic pKa: ┄ | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.56 | Np Likeness Score: -2.11 |
References
1. Scharnow AM, Solinski AE, Wuest WM.. (2019) Targeting S. mutans biofilms: a perspective on preventing dental caries., 10 (7): [PMID:31391878] [10.1039/C9MD00015A] |
2. Nijampatnam B,Ahirwar P,Pukkanasut P,Womack H,Casals L,Zhang H,Cai X,Michalek SM,Wu H,Velu SE. (2021) Discovery of Potent Inhibitors of Streptococcus mutans Biofilm with Antivirulence Activity., 12 (1): [PMID:33488963] [10.1021/acsmedchemlett.0c00373] |